Published 1997 | Version v1
Report Open

Boron neutron capture therapy (BNCT) for glioblastoma multiforme using the epithermal neutron beam at the Brookhaven Medical Research Reactor

  • 1. Brookhaven National Lab., Upton, NY (United States)
  • 2. Univ. Hospital, State Univ. of New York, NY (United States)

Description

The abstract describes evaluation of boron neutron capture therapy (BNCT) for two groups of glioblastoma multiforme patients. From September 1994 to February 1996 15 patients have been treated. In September 1997 another 34 patients were examined. Authors determined a safe starting dose for BNCT using epithermal neutrons and BPA-F. They have also evaluated adverse effects of BNCT at this starting dose. Therapeutic effectiveness of this starting dose has been evaluated. No significant side effects from BPA-F infusion or BNCT treatment were observed in normal brains

Files

30020518.pdf

Files (88.7 kB)

Name Size Download all
md5:9ce21fd9fd6d0d3e1c4d4923ca05ec48
88.7 kB Preview Download
Part of:
Radioactivity: risk and hope. Workshop in memory of Maria Sklodowska-Curie. Book of abstracts

Additional details

Publishing Information

Imprint Title
Radioactivity: risk and hope. Workshop in memory of Maria Sklodowska-Curie. Book of abstracts
Imprint Pagination
49 p.
Journal Page Range
p. 24-26
Report number
INP--1762/B

Conference

Title
risk and hope. Workshop in memory of Maria Sklodowska-Curie
Acronym
Radioactivity
Dates
6-7 Oct 1997
Place
Cracow (Poland)

INIS

Optional Information